Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1675 of 3284 entries
View as:

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT05138133 Org: User:
Start: 02/15/22 End: 07/07/28 Due: 07/07/29

PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of Russia

Phase: N/A Priority: Normal
NCT ID: NCT06372431 Org: User:
Start: 01/15/24 End: 10/31/25 Due: 10/31/26

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06115967 Org: User:
Start: 11/15/23 End: 09/21/26 Due: 09/21/27

Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom

Phase: N/A Priority: Normal
NCT ID: NCT05557695 Org: User:
Start: 10/17/22 End: 04/01/27 Due: 04/01/28

A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD2389

Phase: N/A Priority: Normal
NCT ID: NCT06812780 Org: User:
Start: 02/04/25 End: 08/27/25 Due: 08/27/26

A Study to Investigate the Exposure of Budesonide, Glycopyrronium, and Formoterol (BGF) Delivered by Hydrofluoroolefin (HFO) Propellant Metered Dose Inhaler (MDI) Compared to a Hydrofluoroalkane (HFA) Propellant MDI in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06723756 Org: User:
Start: 01/23/25 End: 06/01/25 Due: 06/01/26

A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Early COPD Outcomes in Chinese Population

Phase: N/A Priority: Normal
NCT ID: NCT06724848 Org: User:
Start: 06/05/24 End: 07/07/27 Due: 07/07/28

Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats

Phase: N/A Priority: Normal
NCT ID: NCT01078662 Org: User:
Start: 02/21/10 End: 08/12/24 Due: 08/12/25

Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of Digoxin

Phase: N/A Priority: Normal
NCT ID: NCT00723424 Org: User:
Start: 07/31/08 End: 12/31/08 Due: 12/31/09

A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX® (Goserelin Acetate Implant) 10.8 mg and ZOLADEX® (Goserelin Acetate Implant) 3.6 mg in Chinese Patients With Localized or Locally Advanced Hormonal Treatment -naïve Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03193060 Org: User:
Start: 09/19/17 End: 12/27/19 Due: 12/27/20

A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition

Phase: N/A Priority: Normal
NCT ID: NCT01044342 Org: User:
Start: 12/31/09 End: 04/30/10 Due: 04/30/11

Bioequivalence Study Coadministered to Healthy Subjects in the Fasted State

Phase: N/A Priority: Normal
NCT ID: NCT02223065 Org: User:
Start: 09/30/14 End: 12/31/14 Due: 12/31/15

A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02406261 Org: User:
Start: 04/30/15 End: 08/31/15 Due: 08/31/16

Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart

Phase: N/A Priority: Normal
NCT ID: NCT01359618 Org: User:
Start: 06/30/11 End: 04/30/12 Due: 04/30/13

Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02500979 Org: User:
Start: 08/17/15 End: 08/05/16 Due: 08/05/17

A Study to Assess the Effect of Fluvoxamine and Smoking on Pharmacokinetics ( the Movement of Drugs Within the Body) of AZD4635 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04478513 Org: User:
Start: 07/21/20 End: 12/23/20 Due: 12/23/21

Observational Study of Obstructive Lung Disease (NOVELTY)

Phase: N/A Priority: Normal
NCT ID: NCT02760329 Org: User:
Start: 07/25/16 End: 05/31/23 Due: 05/31/24

Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT05006573 Org: User:
Start: 07/21/21 End: 04/16/24 Due: 04/16/25

Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00884143 Org: User:
Start: 07/31/09 End: 01/31/10 Due: 01/31/11

To Investigate the Effects of AZD1981 on the QT Interval

Phase: N/A Priority: Normal
NCT ID: NCT01265641 Org: User:
Start: 01/31/11 End: 04/30/11 Due: 04/30/12

Prevalence of Gastroesophageal Reflux Disease in Primary Care Patients With Upper Gastrointestinal Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT01020890 Org: User:
Start: 11/30/09 End: 04/30/10 Due: 04/30/11

To Assess the Safety, Tolerability, Pharmacokinetics and Pharmakodynamics of AZD2820 After Multiple Ascending Doses

Phase: N/A Priority: Normal
NCT ID: NCT01469923 Org: User:
Start: 03/31/12 End: 12/31/12 Due: 12/31/13

A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02413398 Org: User:
Start: 06/15/15 End: 11/07/17 Due: 11/07/18

A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin

Phase: N/A Priority: Normal
NCT ID: NCT01094483 Org: User:
Start: 03/31/10 End: 05/31/10 Due: 05/31/11

Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00669903 Org: User:
Start: 04/30/08 End: 11/30/08 Due: 11/30/09